Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Single- and Repeat-dose Oral Toxicity Studies of Lithospermum erythrorhizon Extract in Dogs

  • Received : 2015.01.09
  • Accepted : 2015.03.05
  • Published : 2015.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Lithospermum erythrorhizon has long been used in traditional Asian medicine for the treatment of diseases, including skin cancer. The oral toxicity of a hexane extract of Lithospermum erythrorhizon root (LEH) was investigated in Beagle dogs by using single escalating doses, two-week dose range-finding, and 4-week oral repeat dosing. In the single dose-escalating oral toxicity study, no animal died, showed adverse clinical signs, or changes in body weight gain at LEH doses of up to 2,000 mg/kg. In a 2 week dose range-finding study, no treatment-related adverse effects were detected by urinalysis, hematology, blood biochemistry, organ weights, or gross and histopathological examinations at doses of up to 500 mg LEH/kg/day. In the 4 week repeat-dose toxicity study, a weight loss or decreased weight gain was observed at 300 mg/kg/day. Although levels of serum triglyceride and total bilirubin were increased in a dose dependent manner, there were no related morphological changes. Based on these findings, the sub-acute no observable adverse effect level for 4-week oral administration of LEH in Beagles was 100 mg/kg/day.

Keywords

References

  1. Chen, X., Yang, L., Oppenheim, J.J. and Howard, M.Z. (2002) Cellular pharmacology studies of shikonin derivatives. Phytother. Res., 16, 199-209. https://doi.org/10.1002/ptr.1100
  2. Rajasekar, S., Park D.J., Park, C., Park, S., Park, Y.H., Kim, S.T., Choi, Y.H. and Choi, Y.W. (2012) In vitro and in vivo anticancer effects of Lithospermum erythrorhizon extract on B16F10 murine melanoma. J. Ethnopharmacol., 144, 335-345. https://doi.org/10.1016/j.jep.2012.09.017
  3. Lee, C.C., Wang, C.N., Lai, Y.T., Kang, J.J., Liao, J.W., Chiang, B.L., Chen, H.C. and Cheng, Y.W. (2010) Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma. Br. J. Pharmacol., 161, 1496-1511. https://doi.org/10.1111/j.1476-5381.2010.00972.x
  4. Andujar, I., Rios, J.L., Giner, R.M. and Recio, M.C. (2013) Shikonin promotes intestinal wound healing in vitro via induction of TGF-${\beta}$ release in IEC-18 cells. Eur. J. Pharm. Sci., 49, 637-641. https://doi.org/10.1016/j.ejps.2013.05.018
  5. Karayannopoulou, M., Tsioli, V., Loukopoulos, P., Anagnostou, T.L., Giannakas, N., Savvas, I., Papazoglou, L.G. and Kaldrymidou, E. (2011) Evaluation of the effectiveness of an ointment based on Alkannins/Shikonins on second intention wound healing in the dog. Can. J. Vet. Res., 75, 42-48.
  6. Min, R., Tong, J., Wenjun, Y., Wenhu, D., Xiaojian, Z., Jiacai, H., Jian, Z., Wantao, C. and Chenping, Z. (2008) Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-kappaB pathway. Phytother. Res., 22, 407-415. https://doi.org/10.1002/ptr.2340
  7. Yingkun, N., Lysong, Z. and Huimin, Y. (2010) Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells. Can. J. Physiol. Pharmacol., 88, 1138-1146. https://doi.org/10.1139/Y10-085
  8. Chang, I.C., Huang, Y.J., Chiang, T.I., Yeh, C.W. and Hsu, L.S. (2010) Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells. Biol. Pharm. Bull., 33, 816-824. https://doi.org/10.1248/bpb.33.816
  9. Mao, X., Yu, C.R., Li, W.H. and Li, W.X. (2008) Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res., 18, 879-888. https://doi.org/10.1038/cr.2008.86
  10. Yang, H., Zhou, P., Huang, H., Chen, D., Ma, N., Cui, Q.C., Shen, S., Dong, W., Zhang, X., Lian, W., Wang, X., Dou, Q.P. and Liu, J. (2009) Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. Int. J. Cancer, 124, 2450-2459. https://doi.org/10.1002/ijc.24195
  11. Lee, H.J., Lee, H.J., Magesh, V., Nam, D., Lee, E.O., Ahn, K.S., Jung, M.H., Ahn, K.S., Kim, D.K., Kim, J.Y. and Kim, S.H. (2008) Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice. Yakugaku Zasshi, 128, 1681-1688. https://doi.org/10.1248/yakushi.128.1681
  12. Chen, C.H., Lin, M.L., Ong, P.L. and Yang, J.T. (2012) Novel multiple apoptotic mechanism of shikonin in human glioma cells. Ann. Surg. Oncol., 19, 3097-3106. https://doi.org/10.1245/s10434-012-2324-4

Cited by

  1. Metabolic profiling study of shikonin's cytotoxic activity in the Huh7 human hepatoma cell line vol.13, pp.5, 2017, https://doi.org/10.1039/C6MB00830E